Press Releases

COUCH Health demands the clinical research industry improves diversity once and for all

As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversity in clinical research, and make change happen.

Luye Pharma Group Selects LifeSphere Signal and Risk Management to Automate Drug Safety Signal Detection

ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, (02186.HK) has selected LifeSphere® Signal and Risk Management as its next-generation signal detection tool. Learn more...

Imvax Appoints Mark Exley, Ph.D. as Chief Scientific Officer

Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO). Reporting to Imvax Chief Executive Officer (CEO) John Furey, Dr. Exley joins the company as it is developing Imvax’s lead product candidate, IGV-001, for the treatment of newly diagnosed glioblastoma multiforme (GBM).

EPS Corporation Signs Groundbreaking Agreement to Drive Increased Quality and Safety Using CluePoints Risk-Based Quality Management Solution

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS, a Tokyo based CRO, have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a cost-effective and resource-efficient manner.

Elsevier’s PharmaPendium and ExactCure reviewing 20 approved drugs for COVID-19 therapies

AI powered ‘digital twins’, using PharmaPendium data, will help physicians improve dosing of COVID-19 therapies with personalized model simulations

TailorMed launches Remote Navigation solution to enable hospital staff to help their patients from afar and ensure that healthcare providers can recover lost revenues

TailorMed today launched the Remote Navigation solution as part of its unique and industry-leading financial navigation solution. It is the first of its kind to enable healthcare providers and their staff to remotely work with patients to ease the patient's and hospital's financial burden. The new product also helps healthcare providers quickly access TailorMed's much larger suite of financial navigation technology and services currently available to TailorMed's 50 client hospitals and medical practices.

SGS Digicomply Launches AI System to Find Answers on COVID-19 within Research Articles

SGS Digicomply has announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding ways to respond to the COVID-19 pandemic.

Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites

Panthera opens for clinical trials in Manchester, its second clinical trial site in the UK, with additional health and safety precautions to protect staff and patients from COVID-19.

Liberty16 being paired with Oxford Nanopore Flongle

ERT Delivers Actionable Insights to Identify COVID-related Clinical Trial Risks

Intuitive COVID-19 Dashboard highlights patient compliance risks to protect study outcomes

TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief

Tufts CSDD-eClinical Solutions Clinical Data Study Shows 32 Percent Increase in Trial Cycle Time Metric

Robust data strategy and improved technology infrastructure to accelerate drug development

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

Patients monitor cardiac safety at home with easy-to-use, FDA-cleared KardiaMobile 6L personal ECG

AMRI Leads the Industry in Highest Ranking from SafeBridge for Highly Potent Compound Safety

AMRI's Rensselaer, NY facility is the first in the industry to achieve Leader Status based on quantitative results of the Potent Compound Safety Certification program administered by SafeBridge.

Profacgen Introduced Trimeric Protein Production Service for Protein Research Field

Elsevier adds to its extensive free resources for biomedical and scientific researchers working on coronavirus with access to broad suite of tools

The Elsevier Coronavirus Research Hub includes access to multiple tools, from scientific and clinical content to COVID-19 specific datasets, text mining services and more

BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics

Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks and buffy coats for COVID-19, cell and gene therapy research within hours of collection.

CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package available to all at no cost. With the FDA, EMA, PMDA and MHRA issuing specific guidelines as a result of the coronavirus, the CluePoints package will help meet these new recommendations and address additional study risks. The platform includes a widely used online Risk Assessment and Control solution that can be leveraged for performing risk planning and mitigation activities addressing inherent risks during this crisis. Register here for the COVID-19 risk management package.

Independent Site Management Organisation Panthera prepares for COVID-19

Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.

Sharp Clinical Supports Development of Novel COVID-19 Vaccines and Treatments

Sharp Clinical, part of UDG Healthcare and a leading provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19.